ELE

ELE sits in a medium-term bullish Stage 2 advance, but remains capped under the declining 200-day SMA. Price is consolidating with flat short-term EMAs in an overbought context, offering no immediate timing edge. A pullback into the rising 50-day SMA near $20.90 (and $21.00 support) provides the structurally favorable entry zone. Execution is best deferred until that area is tested.

• ↑Q2 2026 revenue $24.3M, up 83% YoY from merger synergies
• ↑Cash position of $74M provides flexibility for targeted acquisitions
• ↓Negative earnings yield and subpar profitability score highlight efficiency issues